Theriva Biologics Stock Forecast

Sell candidate since Jun 01, 2026 Gain 2.13%

The Theriva Biologics, Inc. stock price gained 0.699% on the last trading day (Wednesday, 3rd Jun 2026), rising from $0.286 to $0.288. During the last trading day the stock fluctuated 4.58% from a day low at $0.275 to a day high of $0.288. The price has been going up and down for this period, and there has been a 7.91% gain for the last 2 weeks. Volume fell on the last day by -494 thousand shares and in total, 539 thousand shares were bought and sold for approximately $155.27 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.287 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 53.00% during the next 3 months and, with a 90% probability hold a price between $0.440 and $0.756 at the end of this 3-month period.

TOVX Signals & Forecast

There are few to no technical positive signals at the moment. The Theriva Biologics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.291 and $0.326. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 20, 2026, and so far it has fallen -29.76%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Theriva Biologics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.249 and $0.227. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Theriva Biologics, Inc. finds support just below today's level at $0.249. If this is broken, then the next support from accumulated volume will be at $0.227 and $0.223.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0126 between high and low, or 4.58%. For the last week the stock has had daily average volatility of 7.88%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TOVX) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Theriva Biologics, Inc. to open at $0.284, and during the day (based on 14 day Average True Range), to move between $0.274 and $0.302, which gives a possible trading interval of +/-$0.0278 (+/-10.13%) up or down from last closing price. If Theriva Biologics, Inc. takes out the full calculated possible swing range there will be an estimated 10.13% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.297 (3.13%) than the support at $0.249 (13.72%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Theriva Biologics, Inc. stock A Buy?

The Theriva Biologics, Inc. stock holds several negative signals and despite the positive trend, we believe Theriva Biologics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.001 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $0.284 ( 1.46%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk